Skip to main content

Table 1 The relationship between Annexin A2 expression levels and clinical characteristics of NSCLC patients

From: Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells

Variables Annexin A2 p Value
Low (n = 45) High (n = 107)
Age <60 21 55 0.387
≥60 24 52
Gender Male 31 69 0.508
Female 14 38
Tumor size <4 cm 18 37 0.212
≥4 cm 27 70
Histology adenocarcinoma 25 59 0.276
squamous cell carcinoma 20 48
pTNM stage I 19 12 0.012
II-IV 26 95
Lymph node metastasis No 28 47 0.071
Yes 17 60
  1. p values listed are derived from χ2 test